In conclusion, these results suggest that PXDN is highly expressed in tumor cells, which can potentially inhibit T-cell proliferation and infiltration in the microenvironment, which probably contributes to T-cell exhaustion and promotes the immune escape of NPC cells, ultimately promoting NPC progression. Here, PXDN is linked to nasopharyngeal carcinoma.